We are live on ! Find out more
NPA

Nichols & Pratt Advisers Portfolio holdings

AUM $1.65B
1-Year Est. Return 22.9%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+22.9%
3 Year Est. Return
+58.88%
5 Year Est. Return
+87.69%
10 Year Est. Return
+260.41%
AUM
$1.49B
AUM Growth
+$26.6M
Cap. Flow
+$14.6M
Cap. Flow %
0.98%
Top 10 Hldgs %
51.1%
Holding
105
New
9
Increased
45
Reduced
31
Closed
1

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$1.29M
2
NVDA icon
NVIDIA
NVDA
+$1.26M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$959K
4
QCOM icon
Qualcomm
QCOM
+$859K
5
NVO
Novo Nordisk
NVO
+$731K

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$1.26M
2
GPN icon
Global Payments
GPN
+$607K
3
ADP icon
Automatic Data Processing
ADP
+$376K
4
PFE icon
Pfizer
PFE
+$326K
5
SLB icon
SLB Ltd
SLB
+$245K

Sector Composition

Rank Sector Weight
1 Technology 31.92%
2 Healthcare 16.89%
3 Consumer Staples 9.98%
4 Financials 9.03%
5 Industrials 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQV icon
26
IQVIA
IQV
$38.3B
$17.8M 1.2%
112,919
+1,731
+2% +$261K
SO icon
27
Southern Company
SO
$107B
$17.1M 1.15%
186,110
+1,343
+0.7% +$121K
ALC icon
28
Alcon
ALC
$33.9B
$15.5M 1.04%
175,865
+1,495
+0.9% +$134K
APD icon
29
Air Products & Chemicals
APD
$66.8B
$14M 0.94%
49,650
+1,624
+3% +$444K
MDT icon
30
Medtronic
MDT
$110B
$13.8M 0.92%
157,769
+1,383
+0.9% +$117K
CSCO icon
31
Cisco
CSCO
$476B
$13.1M 0.88%
188,305
-3,763
-2% -$231K
TMO icon
32
Thermo Fisher Scientific
TMO
$214B
$11.8M 0.79%
29,202
+1,442
+5% +$603K
XOM icon
33
ExxonMobil
XOM
$642B
$8.24M 0.55%
76,439
-403
-0.5% -$43.1K
GPN icon
34
Global Payments
GPN
$24B
$7.38M 0.5%
92,130
-7,667
-8% -$607K
CVS icon
35
CVS Health
CVS
$123B
$7.07M 0.47%
102,428
+116
+0.1% +$7.61K
SNPS icon
36
Synopsys
SNPS
$77.7B
$6.71M 0.45%
13,061
+2,761
+27% +$1.29M
JPM icon
37
JPMorgan Chase
JPM
$947B
$6.61M 0.44%
22,797
+635
+3% +$162K
NVDA icon
38
NVIDIA
NVDA
$5.3T
$6.22M 0.42%
39,340
+10,000
+34% +$1.26M
GE icon
39
GE Aerospace
GE
$389B
$6.04M 0.41%
23,482
-587
-2% -$129K
STT icon
40
State Street
STT
$50.8B
$5.2M 0.35%
48,862
-650
-1% -$60.1K
COST icon
41
Costco
COST
$421B
$5.09M 0.34%
5,139
+325
+7% +$323K
EMR icon
42
Emerson Electric
EMR
$87.5B
$4.68M 0.31%
35,117
-270
-0.8% -$31K
ABBV icon
43
AbbVie
ABBV
$431B
$4.6M 0.31%
24,764
-600
-2% -$112K
ABT icon
44
Abbott
ABT
$187B
$4.55M 0.31%
33,477
-250
-0.7% -$33K
ECL icon
45
Ecolab
ECL
$79.8B
$4.1M 0.28%
15,230
+10
+0.1% +$2.54K
MKC icon
46
McCormick & Company Non-Voting
MKC
$14.1B
$3.56M 0.24%
46,877
+1,785
+4% +$134K
BHP icon
47
BHP
BHP
$223B
$3.5M 0.23%
72,655
+375
+0.5% +$18K
SHW icon
48
Sherwin-Williams
SHW
$88.2B
$3.21M 0.22%
9,288
+225
+2% +$77.9K
RTX icon
49
RTX Corp
RTX
$301B
$3.1M 0.21%
21,257
V icon
50
Visa
V
$692B
$3.09M 0.21%
8,699
+1,292
+17% +$450K

Similar funds

Nichols & Pratt Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Nichols & Pratt Advisers held 105 positions worth $1.49B, up 1.8% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Nichols & Pratt Advisers's Q2 2025 filing shows 9 new, 45 increased, 31 reduced and 1 closed positions. Its largest new stake was iShares Core S&P Small-Cap ETF: 9,280 shares worth $1.01M. The largest sale was Accenture, an estimated $1.26M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Nichols & Pratt Advisers's largest Q2 2025 buy was iShares Core S&P Small-Cap ETF: 9,280 shares worth $1.01M.
  • Nichols & Pratt Advisers added most to Synopsys in Q2 2025, an estimated $1.29M increase.
  • Nichols & Pratt Advisers's biggest Q2 2025 reduction was Accenture, cutting an estimated $1.26M.
  • Nichols & Pratt Advisers fully exited SLB Ltd in Q2 2025, selling an estimated $245K.
  • Nichols & Pratt Advisers's ten largest holdings make up 51% of its $1.49B portfolio in Q2 2025.
  • Nichols & Pratt Advisers opened 9 new positions and closed 1 in Q2 2025.
  • Nichols & Pratt Advisers's portfolio value rose 1.8% quarter-over-quarter to $1.49B.

Based on Nichols & Pratt Advisers's 13F filing for Q2 2025, filed 5 Aug 2025.